Terelizumab

Lung cancer "no chemotherapy era" or will come to the lung cancer advanced survival or is expected to exceed 5 years?
lung cancer Advanced lung cancer chemotherapy Non-small cell lung cancer Terelizumab Carellizumab
04-29
A number of drugs were approved in one day, including 3 important anti-cancer drugs
Indications Terelizumab anticancer Non-small cell lung cancer Tocilizumab Ensatinib pd-1 BeiGene
04-13
Global layout brings differentiated advantages BeiGene's entire industrial chain capabilities are gradually complete
BeiGene Terelizumab Industrial chain Zebutinib cll
01-26
Yahong Pharmaceutical: APL-1202 and Bai Zean combined neoadjuvant therapy completed the world's first drug administration in the United States
Yahong Pharmaceutical Bai Zean Terelizumab mibc tumor bladder cancer
01-04